Table 1 Correlations berween miR-644a expression and clinicopathological parameters in 135 hepatocellular carcinoma patients
Variables | miR-644a expression | Total | P value | |
|---|---|---|---|---|
Low (72) | High (63) | |||
Age (y) | ||||
< 60 | 21(48%) | 23(52%) | 44 | 0.368 |
≥ 60 | 51(56%) | 40(44%) | 91 | |
Gender | ||||
Male | 48(59%) | 34(41%) | 82 | 0.134 |
Female | 24(45%) | 29(55%) | 53 | |
Tumor diameter (cm) | ||||
< 5 | 20(33%) | 39(67%) | 59 | 0.001a |
≥ 5 | 52(68%) | 24(32%) | 76 | |
AFP (ng/ml) | ||||
< 20 | 26 | 25 | 51 | 0.401 |
≥ 20 | 46 | 38 | 84 | |
Tumor differentiation | ||||
Well | 16(44%) | 20(56%) | 36 | 0.195 |
Moderate | 27(53%) | 15(36%) | 42 | |
Poor | 29(51%) | 28(49%) | 57 | |
TNM stage | ||||
I-II | 25(39%) | 39(61%) | 64 | 0.001a |
III-IV | 47(66%) | 24(34%) | 71 | |
HSF1 expression | ||||
Low | 13(34%) | 25(66%) | 38 | 0.004a |
High | 59(61%) | 37(39%) | 96 | |